A multiparameter optimization in middle-down analysis of monoclonal antibodies by LC-MS/MS.
Jonathan DheninMathieu DupréKaren DruartAlain KrickChristine MauriacJulia Chamot-RookePublished in: Journal of mass spectrometry : JMS (2023)
In antibody-based drug research, a complete characterization of antibody proteoforms covering both the amino acid sequence and all posttranslational modifications remains a major concern. The usual mass spectrometry-based approach to achieve this goal is bottom-up proteomics, which relies on the digestion of antibodies but does not allow the diversity of proteoforms to be assessed. Middle-down and top-down approaches have recently emerged as attractive alternatives but are not yet mastered and thus used in routine by many analytical chemistry laboratories. The work described here aims at providing guidelines to achieve the best sequence coverage for the fragmentation of intact light and heavy chains generated from a simple reduction of intact antibodies using Orbitrap mass spectrometry. Three parameters were found crucial to this aim: the use of an electron-based activation technique, the multiplex selection of precursor ions of different charge states, and the combination of replicates.
Keyphrases
- mass spectrometry
- liquid chromatography
- amino acid
- high resolution mass spectrometry
- gas chromatography
- clinical practice
- high performance liquid chromatography
- tandem mass spectrometry
- capillary electrophoresis
- high resolution
- ultra high performance liquid chromatography
- simultaneous determination
- quantum dots
- high throughput
- flow cytometry
- solid phase extraction
- health insurance
- drug discovery
- affordable care act
- drug induced
- single cell
- electronic health record